Genome & Company
Genome & Company is a South Korean company whose website presents a pipeline spanning a GNOCLE™ platform, microbiome assets, and new biologics.
Last updated October 26, 2026
AI crawler reads
1requests
1companies- Google1
- Profile
- 1
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 5, 2026
- Latest read
- Nov 5, 2026
From this site's server log
Overview
Genome & Company (Korean: 지놈앤컴퍼니) is a South Korean company based in Suwon, Gyeonggi-do. Its official website organizes its activities around a Pipeline section that lists a GNOCLE™ platform, Microbiome assets (GEN-001, SB-121), and New biologics (GENA-104, GENA-120, GENA-121, GENA-122). The site also provides Investor Relations, Public Relations, Careers, and Business Development sections.
History
Genome & Company (Korean: 지놈앤컴퍼니) is a South Korean company headquartered in Suwon, Gyeonggi-do. Its official website presents a Pipeline section covering a GNOCLE™ platform, Microbiome assets (GEN-001, SB-121), and New biologics (GENA-104, GENA-120, GENA-121, GENA-122), alongside Investor Relations, Public Relations, Careers, and Business Development sections.
Products and positioning
GNOCLE™ platform
GEN-001
SB-121
GENA-104
GENA-120
GENA-121
GENA-122
Recent events
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/genome-and-company-south-korea · Editorial policy · How profiles are compiled